We are live on ! Find out more
MDXG icon

MiMedx Group

213 hedge funds and large institutions have $973M invested in MiMedx Group in 2024 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 54 increasing their positions, 65 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 23

68% more capital invested

Capital invested by funds: $580M → $973M (+$394M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

15% more call options, than puts

Call options by funds: $610K | Put options by funds: $529K

10% more funds holding

Funds holding: 194213 (+19)

2.03% more ownership

Funds ownership: 66.83%68.86% (+2%)

17% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 65

Holders
213
Holders Change
+19
Holders Change %
+9.79%
% of All Funds
2.81%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
46
Increased
54
Reduced
65
Closed
23
Calls
$610K
Puts
$529K
Net Calls
+$81K
Net Calls Change
+$509K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$4.72M -$160K -20,492 -4%
AW
27
Apricus Wealth
South Carolina
$4.35M
Citadel Advisors
28
Citadel Advisors
Florida
$4.29M -$1.1K -141 -0%
Norges Bank
29
Norges Bank
Norway
$4.02M +$2.71M +347,500 +494%
Two Sigma Investments
30
Two Sigma Investments
New York
$3.81M -$718K -92,228 -19%
MIM
31
Meros Investment Management
Texas
$3.8M +$3.08M +395,074 New
Wellington Management Group
32
Wellington Management Group
Massachusetts
$3.75M +$564K +72,432 +23%
Jane Street
33
Jane Street
New York
$3.71M +$623K +79,942 +26%
Arrowstreet Capital
34
Arrowstreet Capital
Massachusetts
$3.49M +$2.34M +300,433 +484%
Prudential Financial
35
Prudential Financial
New Jersey
$3.36M -$903K -115,900 -25%
Marshall Wace
36
Marshall Wace
United Kingdom
$3.35M +$1.71K +220 +0.1%
DGI
37
Disciplined Growth Investors
Minnesota
$3.35M -$58K -7,441 -2%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$3.24M +$622K +79,901 +31%
N
39
Nuveen
North Carolina
$2.98M
IP
40
Isthmus Partners
Wisconsin
$2.95M +$3.07K +394 +0.1%
Fisher Asset Management
41
Fisher Asset Management
Washington
$2.63M -$148K -18,979 -7%
Barclays
42
Barclays
United Kingdom
$2.42M -$86.5K -11,098 -4%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$2.34M +$882K +113,191 +87%
Swiss National Bank
44
Swiss National Bank
Switzerland
$2.23M
PCM
45
Prelude Capital Management
New York
$2.22M -$1.3M -166,281 -42%
TI
46
Trexquant Investment
Connecticut
$2.13M +$394K +50,635 +30%
GC
47
Globeflex Capital
California
$2.06M
PFC
48
Phocas Financial Corp
California
$2.02M +$1.63M +209,582 New
SOW
49
State of Wyoming
Wyoming
$1.93M +$220K +28,230 +16%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$1.92M -$767K -98,400 -33%

MDXG Hedge Fund Activity: Q4 2024 in Review

213 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q4 2024, worth a combined $973M — up 68% from $580M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new MDXG positions and 23 closed out — a net gain of 23 holders — while 54 added to existing stakes and 65 trimmed.

The largest buyer was First Light Asset Management, opening a new position worth an estimated $26M. The largest seller was Federated Hermes, cutting an estimated $6.42M.

  • 213 institutional investors held MiMedx Group (MDXG) as of Q4 2024, up from 194 in Q3 2024.
  • Funds reported $973M of MiMedx Group stock for Q4 2024, up 68% quarter-over-quarter.
  • 46 funds opened new MiMedx Group positions in Q4 2024 and 23 closed out, a net change of +23 holders.
  • The largest MiMedx Group buyer in Q4 2024 was First Light Asset Management, an estimated $26M added.
  • The largest MiMedx Group seller in Q4 2024 was Federated Hermes, an estimated $6.42M sold.

Based on aggregated 13F filings for Q4 2024.